Picture of Ambalal Sarabhai Enterprises logo

500009 Ambalal Sarabhai Enterprises Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m+4.63%
3m-12.87%
6m-2.36%
1yr+68.42%
Volume Change (%)
10d/3m-66.24%
Price vs... (%)
52w High-32.34%
50d MA-10.69%
200d MA+13%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.22%
Return on Equity2.31%
Operating Margin-0.18%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueIN₹m1,518.781,334.981,636.431,967.451,702.84n/an/a6.27%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+224.62-15.1+196.27-68.15n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Ambalal Sarabhai Enterprises EPS forecast chart

Profile Summary

Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparation (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Private Limited, is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
June 5th, 1978
Public Since
July 13th, 1993
No. of Shareholders
178,274
No. of Employees
459
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconBombay Stock Exchange
Shares in Issue
76,633,296

500009 Share Price Performance

Upcoming Events for 500009

Q4 2024 Ambalal Sarabhai Enterprises Ltd Earnings Release

Q1 2025 Ambalal Sarabhai Enterprises Ltd Earnings Release

Ambalal Sarabhai Enterprises Ltd Annual Shareholders Meeting

Similar to 500009

Picture of Achyut Healthcare logo

Achyut Healthcare

in flag iconBombay Stock Exchange

Picture of Adline Chem Lab logo

Adline Chem Lab

in flag iconBombay Stock Exchange

Picture of MPS Pharmaa logo

MPS Pharmaa

in flag iconBombay Stock Exchange

Picture of Albert David logo

Albert David

in flag iconBombay Stock Exchange

Picture of ANG Lifesciences India logo

ANG Lifesciences India

in flag iconBombay Stock Exchange

FAQ